TY - JOUR
T1 - Observation of chronic graft-versus-host disease mouse model cornea with in vivo confocal microscopy
AU - Shimizu, Shota
AU - Sato, Shinri
AU - Taniguchi, Hiroko
AU - Shimizu, Eisuke
AU - He, Jingliang
AU - Hayashi, Shunsuke
AU - Negishi, Kazuno
AU - Ogawa, Yoko
AU - Shimmura, Shigeto
N1 - Funding Information:
Funding: This research was supported from the Japanese Ministry of Education, Science, Sports, Culture and Technology to E.S., grant number 20K18394, S.H., grant number 20K18358 and Y.O, grant number 21K09752.
Funding Information:
This research was supported from the Japanese Ministry of Education, Science, Sports, Culture and Technology to E.S., grant number 20K18394, S.H., grant number 20K18358 and Y.O, grant number 21K09752. We thank the Collaborative Research Resources, School of Medicine, Keio University for technical assistance.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/8
Y1 - 2021/8
N2 - Graft-versus-host disease (GVHD) is a major complication after hematopoietic stem cell transplantation (HSCT), and ocular GVHD can cause severe dry eye disease that can lead to visual impairment. Epithelial damage, vascular invasion, corneal fibrosis, and corneal perforation may occur in severe cases. It is generally accepted that inflammatory cells such as dendritic cells and T cells contribute to this pathological condition. However, it is still unknown what pathological condition occurs on the ocular surface after HSCT, and when. We therefore observed the dynamics of inflammatory cells in the cornea of chronic GVHD (cGVHD) model mice from 1 to 4 weeks after bone marrow transplantation (BMT) by in vivo confocal microscopy (IVCM) and considered the relationship with the pathophysiology of ocular GVHD (tear volume, corneal epithelial damage). In the allogeneic group, neovascularization occurred in all eyes at 1 week after BMT, although almost all vessels disappeared at 2 weeks after BMT. In addition, we revealed that infiltration of globular cells, and tortuosity and branching of nerves in the cornea occurred in both cGVHD mice and human cGVHD patients. Thus, we consider that cGVHD mouse model study by IVCM reproduces the state of ocular GVHD and may contribute to elucidating the pathological mechanism for ocular GVHD.
AB - Graft-versus-host disease (GVHD) is a major complication after hematopoietic stem cell transplantation (HSCT), and ocular GVHD can cause severe dry eye disease that can lead to visual impairment. Epithelial damage, vascular invasion, corneal fibrosis, and corneal perforation may occur in severe cases. It is generally accepted that inflammatory cells such as dendritic cells and T cells contribute to this pathological condition. However, it is still unknown what pathological condition occurs on the ocular surface after HSCT, and when. We therefore observed the dynamics of inflammatory cells in the cornea of chronic GVHD (cGVHD) model mice from 1 to 4 weeks after bone marrow transplantation (BMT) by in vivo confocal microscopy (IVCM) and considered the relationship with the pathophysiology of ocular GVHD (tear volume, corneal epithelial damage). In the allogeneic group, neovascularization occurred in all eyes at 1 week after BMT, although almost all vessels disappeared at 2 weeks after BMT. In addition, we revealed that infiltration of globular cells, and tortuosity and branching of nerves in the cornea occurred in both cGVHD mice and human cGVHD patients. Thus, we consider that cGVHD mouse model study by IVCM reproduces the state of ocular GVHD and may contribute to elucidating the pathological mechanism for ocular GVHD.
KW - Bone marrow transplantation
KW - Dry eye disease
KW - Graft-versus-host disease
KW - Hematopoietic stem cell transplantation
KW - In vivo confocal microscopy
UR - http://www.scopus.com/inward/record.url?scp=85114084545&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114084545&partnerID=8YFLogxK
U2 - 10.3390/diagnostics11081515
DO - 10.3390/diagnostics11081515
M3 - Article
AN - SCOPUS:85114084545
SN - 2075-4418
VL - 11
JO - Diagnostics
JF - Diagnostics
IS - 8
M1 - 1515
ER -